October 06, 2022
Will Manufacturing Be the Stumbling Block for T-Cell Therapies?
Related News
-
November 12, 2024Cellares Appoints Ossama Eissa, Former Novartis, Lonza, and Legend Biopharma Leader as Chief Operating Officer
-
September 12, 2024
Cellares and Sony Announce a Joint Development Collaboration to Integrate Flow Cytometry-Based Sorting and Online Analysis into an Automated, High-Throughput Cell Therapy Manufacturing Platform
-
September 05, 2024
Cellares Announces Completion of First cGMP Cell Shuttle at IDMO Smart Factory in Bridgewater, New Jersey
